Showing results (21-30 of 176) with videos related to
Sort By:
Pageof 18
Current Opinion in Psychiatry|January 5, 2013
Alternative pharmacologic targets for the treatment of schizophrenia: results from phase I and II trialsSeiya Miyamoto, Lars F Jarskog, W Wolfgang FleischhackerSchizophrenia Research|May 1, 2012
Interpreting treatment trials in schizophrenia patients: lessons learned from EUFESTW Wolfgang Fleischhacker, Eske Derks, Rene S KahnEssential Psychopharmacology|March 16, 2005
Olanzapine-induced weight gain and disturbances of lipid and glucose metabolismUrsula eder-Ischia, Christoph Ebenbichler, W Wolfgang FleischhackerJournal of Psychiatric Research|July 30, 2014
New therapeutic approaches for treatment-resistant schizophrenia: a look to the futureSeiya Miyamoto, L Fredrik Jarskog, W Wolfgang FleischhackerCurrent Opinion in Psychiatry|March 14, 2015
Schizophrenia: when clozapine failsSeiya Miyamoto, Lars Fredrik Jarskog, W Wolfgang FleischhackerThe Journal of Clinical Psychiatry|December 19, 2003
Factors influencing compliance in schizophrenia patientsW Wolfgang Fleischhacker, Maria A Oehl, Martina HummerCurrent Opinion in Investigational Drugs (London, England : 2000)|September 25, 2009
Experimental antipsychotics and metabolic adverse effects--findings from clinical trialsAlexander Tschoner, W Wolfgang Fleischhacker, Christoph F EbenbichlerPsychopharmacology|July 11, 2002
The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophreniaElisabeth M Weiss, Robert M Bilder, W Wolfgang FleischhackerCurrents in Pharmacy Teaching & Learning|April 19, 2021
Problem-based learning case studies: Delivery of an educational method and perceptions at two schools of pharmacy in ItalyCourtney A Montepara, Amy G Woods, Kurt W WolfgangArchives of General Psychiatry|December 7, 2005
Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysisGeorg Kemmler, Martina Hummer, Christian Widschwendter, et al.Pageof 18